Healthcare financing addresses three questions: how money is raised (taxation, social insurance contributions, private premiums, out-of-pocket payments), how it is pooled (risk pooling across populations to protect individuals from catastrophic costs), and how providers are paid (fee-for-service, capitation, salary, DRG-based payments). Major financing models include the Beveridge model (tax-funded, government-provided, e.g., UK's NHS), the Bismarck model (employer-employee social insurance with regulated private providers, e.g., Germany, France), the National Health Insurance model (tax-funded but private providers, e.g., Canada), and the market-based model (employer-sponsored private insurance with safety-net programs, e.g., US). Each model reflects different tradeoffs between equity, efficiency, choice, and cost control, and no country uses a pure model — all are hybrids with elements of multiple systems.
Every healthcare system must answer three financial questions. Revenue raising: where does the money come from? Pooling: how is financial risk shared across the population? Purchasing: how are providers paid, and what incentives does the payment method create? The answers to these questions define the financing model and shape the system's performance on equity, efficiency, and access.
The Beveridge model (UK, Spain, Scandinavia) raises revenue through general taxation and provides care through government-owned facilities staffed by salaried physicians. Pooling is universal and automatic — everyone is covered by virtue of citizenship or residence. Cost control is strong (the government sets the budget), but access may be rationed through waiting times. The Bismarck model (Germany, France, Japan) raises revenue through mandatory payroll-based social insurance contributions, shared between employers and employees, and channels funds through non-profit insurers (sickness funds). Providers are typically private but heavily regulated. Coverage is nearly universal because participation is compulsory.
The National Health Insurance model (Canada, South Korea, Taiwan) combines tax funding (like Beveridge) with private provision (like Bismarck). A single public payer covers everyone, negotiating prices with private providers. This achieves universal coverage with lower administrative costs than multi-payer systems. The market model (predominantly the US) relies on employer-sponsored private insurance, supplemented by public programs for the elderly (Medicare), the poor (Medicaid), and veterans (VA). This results in a uniquely fragmented system with high administrative costs, uneven coverage, and limited central price negotiation.
No country uses a pure model. The UK has private insurance alongside the NHS. Germany has private insurance as an opt-out for high earners. The US has single-payer-like programs (Medicare, VA) alongside private insurance. The key economic insight is that every financing choice involves tradeoffs. Tax funding is progressive but gives government control over the healthcare budget (with political pressures to underspend). Social insurance preserves employment-linked coverage but may discourage hiring. Private insurance preserves consumer choice but creates adverse selection, administrative waste, and coverage gaps. Understanding these tradeoffs — rather than idealizing any single model — is the foundation of health policy analysis.